Surgical outcome of severe pulmonary arterial hypertension secondary to left-to-right shunt lesions.
10.3345/kjp.2010.53.2.195
- Author:
Cha Gon LEE
1
;
Su In JEONG
;
June HUH
;
I Seok KANG
;
Heung Jae LEE
;
Ji Hyuk YANG
;
Tae Gook JUN
Author Information
1. Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. kis4298@gmail.com
- Publication Type:Original Article
- Keywords:
Pulmonary hypertension;
Balloon occlusion;
Congenital heart disease;
Surgery
- MeSH:
Balloon Occlusion;
Ductus Arteriosus, Patent;
Follow-Up Studies;
Heart;
Heart Diseases;
Heart Septal Defects, Atrial;
Heart Septal Defects, Ventricular;
Humans;
Hypertension;
Hypertension, Pulmonary;
New York;
Pulmonary Artery;
Retrospective Studies;
Wood
- From:Korean Journal of Pediatrics
2010;53(2):195-202
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Despite recent advances in pulmonary hypertension management and surgery, appropriate guidelines remain to be developed for operability in congenital heart disease with pulmonary artery hypertension (PAH). Our aim was to evaluate clinical outcomes of patients with severe PAH who underwent surgical closure of left-to-right shunt lesions (LRSL) on the basis of pulmonary reactivity. METHODS: We retrospectively reviewed 21 patients who underwent surgical closure of LRSL with severe PAH (> or =8 Wood unit) from January 1995 to April 2009. The median age at operation was 26 years. Atrial septal defect, ventricular septal defect (VSD), VSD and patent ductus arteriosus (PDA), and PDA was present in 11, 4, 4, and 2 patients, respectively. RESULTS: Operability was based on vasoreactivity of PAH. Of the 21 patients, 5 showed response to pulmonary vasodilator therapy and 8 showed vasoreactivity after balloon occlusion of defects. The remaining 8 patients were considered operable because of significant left-to-right shunt (Qp/Qs > or =1.5). Five patients underwent total closure of defects and 16 were left with small residual shunts. The median follow-up duration was 32 months. There was no significant postoperative mortality or morbidity. Systolic pulmonary artery pressure (PAP) decreased in all but 2 patients. All patients except 1 showed improvement of New York Heart Association functional class. CONCLUSION: Closure of LRSL in patients with severe PAH on the basis of pulmonary vasoreactivity seems reasonable. PAP and clinical symptoms improved in most patients. Further research is needed for the evaluation of long-term results.
